These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33906710)

  • 1. Expression of PD1 and BTLA on the CD8
    Bao Y; Mo JF; Wu JY; Cao CX
    Chin Med Sci J; 2019 Nov; 34(4):248-255. PubMed ID: 33906710
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral PD1-positive CD4 T-Lymphocyte Count Can Predict Progression-free Survival in Patients With Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor.
    Inomata M; Kado T; Okazawa S; Imanishi S; Taka C; Kambara K; Hirai T; Tanaka H; Tokui K; Hayashi K; Miwa T; Hayashi R; Matsui S; Tobe K
    Anticancer Res; 2019 Dec; 39(12):6887-6893. PubMed ID: 31810958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIGIT presents earlier expression dynamic than PD-1 in activated CD8
    Hu F; Wang W; Fang C; Bai C
    Exp Cell Res; 2020 Nov; 396(1):112260. PubMed ID: 32890458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes and clinical significance of innate-like lymphocyte subsets in peripheral blood of patients with advanced non-small cell lung cancer].
    Wei T; Han X; Xia X; Ma F; Yao C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 May; 32(5):671-5. PubMed ID: 27126948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer.
    Zhang Y; Huang S; Gong D; Qin Y; Shen Q
    Cell Mol Immunol; 2010 Sep; 7(5):389-95. PubMed ID: 20514052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients.
    Dalle S; Verronese E; N'Kodia A; Bardin C; Rodriguez C; Andrieu T; Eberhardt A; Chemin G; Hasan U; Le-Bouar M; Caramel J; Amini-Adle M; Bendriss-Vermare N; Dubois B; Caux C; Ménétrier-Caux C
    Oncoimmunology; 2024; 13(1):2372118. PubMed ID: 38939518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing the percentage of different PD-1
    Hu X; Gu Y; Li D; Zhao S; Hua S; Jiang Y
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1074-1083. PubMed ID: 31381177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evodiamine suppresses non-small cell lung cancer by elevating CD8
    Jiang ZB; Huang JM; Xie YJ; Zhang YZ; Chang C; Lai HL; Wang W; Yao XJ; Fan XX; Wu QB; Xie C; Wang MF; Leung EL
    J Exp Clin Cancer Res; 2020 Nov; 39(1):249. PubMed ID: 33208183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma.
    Uryvaev A; Passhak M; Hershkovits D; Sabo E; Bar-Sela G
    Med Oncol; 2018 Jan; 35(3):25. PubMed ID: 29388007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations of the expression of γδ T cells and their co-stimulatory molecules TIGIT, PD-1, ICOS and BTLA with PR and PIBF in the peripheral blood and decidual tissues of women with unexplained recurrent spontaneous abortion.
    Liang Q; Tong L; Xiang L; Shen S; Pan C; Liu C; Zhang H
    Clin Exp Immunol; 2021 Jan; 203(1):55-65. PubMed ID: 33017473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical significance of B and T lymphocyte attenuator on CD4
    Shen X; Zhang J; Tang P; Song H; Liu X; Huang Z; Zhang X; Wang X; Wu M
    Indian J Pathol Microbiol; 2019; 62(2):232-238. PubMed ID: 30971546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of peripheral T cell clones during PD-1 blockade in non-small cell lung cancer.
    Zhang F; Bai H; Gao R; Fei K; Duan J; Zhang Z; Wang J; Hu X
    Cancer Immunol Immunother; 2020 Dec; 69(12):2599-2611. PubMed ID: 32591861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28 family of receptors on T cells in chronic HBV infection: Expression characteristics, clinical significance and correlations with PD-1 blockade.
    Tang ZS; Hao YH; Zhang EJ; Xu CL; Zhou Y; Zheng X; Yang DL
    Mol Med Rep; 2016 Aug; 14(2):1107-16. PubMed ID: 27314219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T lymphocyte subsets and PD-1 expression on lymphocytes in peripheral blood of patients with non-small cell lung cancer.
    Chen T; Chen H; Lu W; Yao Y
    Medicine (Baltimore); 2022 Oct; 101(42):e31307. PubMed ID: 36281084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
    Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M
    Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non-small Cell Lung Cancer Patients.
    de Goeje PL; Poncin M; Bezemer K; Kaijen-Lambers MEH; Groen HJM; Smit EF; Dingemans AC; Kunert A; Hendriks RW; Aerts JGJV
    Clin Cancer Res; 2019 Apr; 25(7):2219-2227. PubMed ID: 30642911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1.
    Fourcade J; Sun Z; Pagliano O; Guillaume P; Luescher IF; Sander C; Kirkwood JM; Olive D; Kuchroo V; Zarour HM
    Cancer Res; 2012 Feb; 72(4):887-96. PubMed ID: 22205715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD161
    Qu J; Li Y; Wu B; Shen Q; Chen L; Sun W; Wang B; Ying L; Wu L; Zhou H; Zhou J; Zhou J
    Oncoimmunology; 2024; 13(1):2371575. PubMed ID: 38952673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insufficient CD100 shedding contributes to suppression of CD8
    Wang HM; Zhang XH; Ye LQ; Zhang K; Yang NN; Geng S; Chen J; Zhao SX; Yang KL; Fan FF
    Immunology; 2020 Jun; 160(2):209-219. PubMed ID: 32149403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.